From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria

Abstract Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and herit...

Full description

Saved in:
Bibliographic Details
Published inHuman molecular genetics Vol. 27; no. 7; pp. 1164 - 1173
Main Authors Lenglet, Hugo, Schmitt, Caroline, Grange, Thomas, Manceau, Hana, Karboul, Narjesse, Bouchet-Crivat, Florian, Robreau, Anne-Marie, Nicolas, Gael, Lamoril, Jerôme, Simonin, Sylvie, Mirmiran, Arienne, Karim, Zoubida, Casalino, Enrique, Deybach, Jean-Charles, Puy, Hervé, Peoc'h, Katell, Gouya, Laurent
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.04.2018
Oxford University Press (OUP)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.
AbstractList Abstract Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.
Author Deybach, Jean-Charles
Lenglet, Hugo
Nicolas, Gael
Bouchet-Crivat, Florian
Mirmiran, Arienne
Karboul, Narjesse
Simonin, Sylvie
Schmitt, Caroline
Gouya, Laurent
Grange, Thomas
Robreau, Anne-Marie
Manceau, Hana
Casalino, Enrique
Puy, Hervé
Lamoril, Jerôme
Peoc'h, Katell
Karim, Zoubida
Author_xml – sequence: 1
  givenname: Hugo
  surname: Lenglet
  fullname: Lenglet, Hugo
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 2
  givenname: Caroline
  surname: Schmitt
  fullname: Schmitt, Caroline
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 3
  givenname: Thomas
  surname: Grange
  fullname: Grange, Thomas
  organization: INSERM UMR_S1048 Laboratory for Vascular Translational Science (LVTS) Université Paris Diderot, F-75018 Paris, France
– sequence: 4
  givenname: Hana
  surname: Manceau
  fullname: Manceau, Hana
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 5
  givenname: Narjesse
  surname: Karboul
  fullname: Karboul, Narjesse
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 6
  givenname: Florian
  surname: Bouchet-Crivat
  fullname: Bouchet-Crivat, Florian
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 7
  givenname: Anne-Marie
  surname: Robreau
  fullname: Robreau, Anne-Marie
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 8
  givenname: Gael
  surname: Nicolas
  fullname: Nicolas, Gael
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 9
  givenname: Jerôme
  surname: Lamoril
  fullname: Lamoril, Jerôme
  organization: Département de Génétique, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Bichat, F-75018 Paris, France
– sequence: 10
  givenname: Sylvie
  surname: Simonin
  fullname: Simonin, Sylvie
  organization: Centre Français des Porphyries, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Louis Mourier, F-92701 Colombes, France
– sequence: 11
  givenname: Arienne
  surname: Mirmiran
  fullname: Mirmiran, Arienne
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 12
  givenname: Zoubida
  surname: Karim
  fullname: Karim, Zoubida
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 13
  givenname: Enrique
  surname: Casalino
  fullname: Casalino, Enrique
  organization: Département des Urgences, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Bichat, F-75018 Paris, France
– sequence: 14
  givenname: Jean-Charles
  surname: Deybach
  fullname: Deybach, Jean-Charles
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 15
  givenname: Hervé
  surname: Puy
  fullname: Puy, Hervé
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 16
  givenname: Katell
  surname: Peoc'h
  fullname: Peoc'h, Katell
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
– sequence: 17
  givenname: Laurent
  surname: Gouya
  fullname: Gouya, Laurent
  email: laurent.gouya@inserm.fr
  organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29360981$$D View this record in MEDLINE/PubMed
https://hal.science/hal-02351445$$DView record in HAL
BookMark eNp90cFu1DAQBmALFdFt4cIDIF-QoFKonThOfKwqSpFW4gJny7EnG6PYDrZTtG-PV2k5oIqTR9b3z2H-C3TmgweE3lLyiRLRXE_ucG3MkTTkBdpRxklVk745QzsiOKu4IPwcXaT0kxDKWdO9Que1aDgRPd2heBeDwwqb4KxXPuMcsPI4zPYQDuCtxi4YmHEYsfUTRJuV14B_2zxh8A82Bu_AZzWfnB0txFQgVnrNUIYM0dmci8BLiMt0jFa9Ri9HNSd48_heoh93n7_f3lf7b1--3t7sK930Xa5aQ5RgQOuR66HnQ8cZ1CMzreLMDIbSgcHQkqYeAWoyNi0VQ99pDT2vTUehuUQft72TmuUSrVPxKIOy8v5mL09_pC4hxtoHWuyHzS4x_FohZels0jDPykNYk6RCkL6lnegKffdI18GB-bv56aYFkA3oGFKKMEpdrpZt8DkqO0tK5Kk2WWqTW20lcvVP5Gnrs_j9hsO6_M_9AaiZqAQ
CitedBy_id crossref_primary_10_3389_fgene_2023_1333111
crossref_primary_10_1016_j_rceng_2019_10_011
crossref_primary_10_3390_diagnostics12071618
crossref_primary_10_1080_23808993_2021_1838275
crossref_primary_10_1016_j_ymgmr_2018_07_007
crossref_primary_10_5582_irdr_2020_03082
crossref_primary_10_1002_2211_5463_13490
crossref_primary_10_2147_CEG_S348507
crossref_primary_10_1055_a_1282_1156
crossref_primary_10_1002_jmd2_12336
crossref_primary_10_1016_j_amjms_2021_03_004
crossref_primary_10_1111_joim_13463
crossref_primary_10_2147_DDDT_S281631
crossref_primary_10_1002_hep_30936
crossref_primary_10_1111_liv_16012
crossref_primary_10_1080_13696998_2020_1835306
crossref_primary_10_1016_j_ymgme_2018_09_002
crossref_primary_10_5005_jp_journals_10071_24133
crossref_primary_10_1007_s00108_018_0509_z
crossref_primary_10_1016_j_ymgme_2018_10_008
crossref_primary_10_1002_jmd2_12281
crossref_primary_10_1097_MOG_0000000000000734
crossref_primary_10_1016_j_molmed_2018_11_003
crossref_primary_10_1053_j_gastro_2019_04_050
crossref_primary_10_1016_j_ymgme_2020_02_003
crossref_primary_10_1111_liv_15924
crossref_primary_10_1002_ajmg_a_62377
crossref_primary_10_1016_j_ymgme_2018_11_012
crossref_primary_10_1111_cge_13558
crossref_primary_10_1016_j_cgh_2022_09_022
crossref_primary_10_3390_diagnostics11091628
crossref_primary_10_1007_s40291_019_00438_6
crossref_primary_10_1055_s_0044_1787076
crossref_primary_10_3389_fgene_2024_1374965
crossref_primary_10_1038_s41390_018_0011_2
crossref_primary_10_1186_s13023_022_02314_9
crossref_primary_10_3390_metabo15020099
crossref_primary_10_1002_ajmg_a_63617
crossref_primary_10_1053_j_gastro_2022_11_034
crossref_primary_10_20344_amp_20323
crossref_primary_10_1002_jimd_12612
crossref_primary_10_3390_life13091923
crossref_primary_10_1016_j_rce_2019_10_012
crossref_primary_10_1016_j_ymgme_2018_12_006
crossref_primary_10_1016_j_jhep_2019_05_003
crossref_primary_10_1016_j_ymthe_2019_11_010
crossref_primary_10_1111_joim_13443
crossref_primary_10_1016_j_ymgmr_2022_100842
crossref_primary_10_3390_diagnostics11081343
crossref_primary_10_1016_j_rce_2024_04_003
crossref_primary_10_1016_j_ymgme_2022_01_002
crossref_primary_10_1016_j_rceng_2024_04_010
crossref_primary_10_1007_s00439_024_02680_3
crossref_primary_10_1016_S1245_1789_22_47082_X
crossref_primary_10_1016_j_jhep_2022_05_018
crossref_primary_10_1016_j_ymgme_2018_10_001
crossref_primary_10_1016_j_ymgme_2018_12_010
crossref_primary_10_3390_biomedicines10030648
crossref_primary_10_1136_jclinpath_2021_207647
crossref_primary_10_3390_life12122059
crossref_primary_10_1002_ajmg_c_31619
crossref_primary_10_1016_j_ajhg_2023_08_012
crossref_primary_10_3390_diagnostics11101795
crossref_primary_10_1111_bph_15040
crossref_primary_10_1182_blood_2022018662
crossref_primary_10_1002_jimd_12809
crossref_primary_10_35754_0234_5730_2019_64_2_123_137
crossref_primary_10_1186_s13023_024_03287_7
crossref_primary_10_1055_a_2096_5899
crossref_primary_10_3390_ijms22020675
crossref_primary_10_1002_lt_25959
crossref_primary_10_1111_febs_16982
crossref_primary_10_7759_cureus_44260
Cites_doi 10.1016/S0140-6736(09)61925-5
10.1034/j.1399-0004.2002.620406.x
10.1038/ki.2015.97
10.1016/j.clinre.2015.05.009
10.1002/1098-1004(200010)16:4<373::AID-HUMU14>3.0.CO;2-A
10.1007/s00439-002-0769-4
10.1136/jmg.32.12.979
10.1086/515455
10.1111/j.1365-2796.2011.02358.x
10.1093/hmg/4.2.215
10.1159/000459098
10.1002/humu.23067
10.1086/301844
10.1007/BF00420949
10.1172/JCI114869
10.1093/hmg/2.8.1315
10.1007/s10545-012-9544-4
10.1046/j.1365-2796.2000.00743.x
10.1093/bioinformatics/btv195
10.1007/BF03401859
10.1056/NEJM199806183382518
10.1007/BF00218912
10.1159/000067665
10.1007/s004390050480
10.1038/nmeth0410-248
10.1136/jclinpath-2012-200791
10.1042/BJ20082077
10.1046/j.1365-2796.1997.00189.x
10.1086/302729
ContentType Journal Article
Copyright The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
DOI 10.1093/hmg/ddy030
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1460-2083
EndPage 1173
ExternalDocumentID oai_HAL_hal_02351445v1
29360981
10_1093_hmg_ddy030
10.1093/hmg/ddy030
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GrantInformation_xml – fundername: French National Research Agency
  grantid: ANR-11-IDEX-0005-02
  funderid: 10.13039/501100001665
GroupedDBID ---
-DZ
-E4
.2P
.I3
.XZ
.ZR
0R~
18M
1TH
29I
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAVLN
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ARIXL
ATGXG
AXUDD
AYOIW
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
EBS
EE~
EJD
EMOBN
F5P
F9B
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NU-
O9-
OAWHX
OBC
OBOKY
OBS
OCZFY
ODMLO
OEB
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RIG
ROL
ROX
ROZ
RUSNO
RW1
RXO
SJN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
XSW
YAYTL
YKOAZ
YXANX
ZKX
~91
AAYXX
ABDFA
ABEJV
ABGNP
ABPQP
ABVGC
ABXZS
ADNBA
AFYAG
AGORE
AHMMS
AJBYB
AJNCP
ALXQX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
ID FETCH-LOGICAL-c387t-5d0a94e12f6cb86b764e2f4d5a64dbd11b4eb5032fee20f3519b87cce862d71e3
ISSN 0964-6906
1460-2083
IngestDate Fri May 09 12:08:31 EDT 2025
Fri Jul 11 07:05:46 EDT 2025
Wed Feb 19 02:32:32 EST 2025
Thu Jul 03 08:37:23 EDT 2025
Thu Apr 24 23:03:37 EDT 2025
Wed Sep 11 04:52:53 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c387t-5d0a94e12f6cb86b764e2f4d5a64dbd11b4eb5032fee20f3519b87cce862d71e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3724-5592
0000-0002-1671-8274
OpenAccessLink https://academic.oup.com/hmg/article-pdf/27/7/1164/24398860/ddy030.pdf
PMID 29360981
PQID 1990851797
PQPubID 23479
PageCount 10
ParticipantIDs hal_primary_oai_HAL_hal_02351445v1
proquest_miscellaneous_1990851797
pubmed_primary_29360981
crossref_citationtrail_10_1093_hmg_ddy030
crossref_primary_10_1093_hmg_ddy030
oup_primary_10_1093_hmg_ddy030
PublicationCentury 2000
PublicationDate 20180401
2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 20180401
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Human molecular genetics
PublicationTitleAlternate Hum Mol Genet
PublicationYear 2018
Publisher Oxford University Press
Oxford University Press (OUP)
Publisher_xml – name: Oxford University Press
– name: Oxford University Press (OUP)
References Pallet ( key 20180319053713_ddy030-B10) 2015; 88
Puy ( key 20180319053713_ddy030-B1) 2010; 375
Almasy ( key 20180319053713_ddy030-B29) 1998; 62
Nordmann ( key 20180319053713_ddy030-B19) 1997; 242
Floderus ( key 20180319053713_ddy030-B4) 2002; 62
Stewart ( key 20180319053713_ddy030-B13) 2012; 65
Chen ( key 20180319053713_ddy030-B24) 2002; 111
Schuurmans ( key 20180319053713_ddy030-B17) 2001; 7
Puy ( key 20180319053713_ddy030-B2) 1997; 60
Elder ( key 20180319053713_ddy030-B6) 2013; 36
Andant ( key 20180319053713_ddy030-B9) 1998; 338
Exner ( key 20180319053713_ddy030-B25) 2001; 8
Llewellyn ( key 20180319053713_ddy030-B31) 1993; 2
Siervi ( key 20180319053713_ddy030-B32) 2000; 16
Adzhubei ( key 20180319053713_ddy030-B27) 2010; 7
Dar ( key 20180319053713_ddy030-B7) 2010; 9
Anderson ( key 20180319053713_ddy030-B26) 1982; 28
Di Pierro ( key 20180319053713_ddy030-B16) 2006; 119
Kauppinen ( key 20180319053713_ddy030-B15) 1995; 4
Falconer ( key 20180319053713_ddy030-B30) 1996
Karim ( key 20180319053713_ddy030-B12) 2015; 39
Andersson ( key 20180319053713_ddy030-B11) 2000; 248
Delfau ( key 20180319053713_ddy030-B14) 1990; 86
Kimpara ( key 20180319053713_ddy030-B22) 1997; 100
Choi ( key 20180319053713_ddy030-B28) 2015; 31
Hrdinka ( key 20180319053713_ddy030-B18) 2006; 55 (Suppl. 2)
Mgone ( key 20180319053713_ddy030-B33) 1993; 92
Lundin ( key 20180319053713_ddy030-B34) 1995; 32
Deybach ( key 20180319053713_ddy030-B8) 2011; 269
Yamada ( key 20180319053713_ddy030-B23) 2000; 66
Schneider-Yin ( key 20180319053713_ddy030-B5) 2002; 54
Gu ( key 20180319053713_ddy030-B3) 1994; 93
Chen ( key 20180319053713_ddy030-B20) 2016; 37
Gill ( key 20180319053713_ddy030-B21) 2009; 420
References_xml – volume: 375
  start-page: 924
  year: 2010
  ident: key 20180319053713_ddy030-B1
  article-title: Porphyrias
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61925-5
– volume: 62
  start-page: 288
  year: 2002
  ident: key 20180319053713_ddy030-B4
  article-title: Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene
  publication-title: Clin. Genet
  doi: 10.1034/j.1399-0004.2002.620406.x
– volume: 119
  start-page: 364
  year: 2006
  ident: key 20180319053713_ddy030-B16
  article-title: Gene symbol: HMBS. Disease: porphyria, acute intermittent
  publication-title: Hum. Genet
– volume-title: Introduction to Quantitative Genetics
  year: 1996
  ident: key 20180319053713_ddy030-B30
– volume: 88
  start-page: 386
  year: 2015
  ident: key 20180319053713_ddy030-B10
  article-title: High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria
  publication-title: Kidney Int
  doi: 10.1038/ki.2015.97
– volume: 39
  start-page: 412
  year: 2015
  ident: key 20180319053713_ddy030-B12
  article-title: Porphyrias: a 2015 update
  publication-title: Clin. Res. Hepatol. Gastroenterol
  doi: 10.1016/j.clinre.2015.05.009
– volume: 8
  start-page: 433
  year: 2001
  ident: key 20180319053713_ddy030-B25
  article-title: Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty
  publication-title: J. Endovasc. Ther. Off. J. Int. Soc. Endovasc. Spec
– volume: 16
  start-page: 373.
  year: 2000
  ident: key 20180319053713_ddy030-B32
  article-title: Identification and characterization of two novel mutations that produce acute intermittent porphyria: a 3-base deletion (841-843delGGA) and a missense mutation (T35M)
  publication-title: Hum. Mutat
  doi: 10.1002/1098-1004(200010)16:4<373::AID-HUMU14>3.0.CO;2-A
– volume: 111
  start-page: 1
  year: 2002
  ident: key 20180319053713_ddy030-B24
  article-title: Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
  publication-title: Hum. Genet
  doi: 10.1007/s00439-002-0769-4
– volume: 9
  start-page: 93
  year: 2010
  ident: key 20180319053713_ddy030-B7
  article-title: Liver transplantation for acute intermittent porphyria: a viable treatment?
  publication-title: Hepatobiliary Pancreat. Dis. Int
– volume: 32
  start-page: 979
  year: 1995
  ident: key 20180319053713_ddy030-B34
  article-title: Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria
  publication-title: J. Med. Genet
  doi: 10.1136/jmg.32.12.979
– volume: 60
  start-page: 1373
  year: 1997
  ident: key 20180319053713_ddy030-B2
  article-title: Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria
  publication-title: Am. J. Hum. Genet
  doi: 10.1086/515455
– volume: 269
  start-page: 521
  year: 2011
  ident: key 20180319053713_ddy030-B8
  article-title: Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa
  publication-title: J. Intern. Med
  doi: 10.1111/j.1365-2796.2011.02358.x
– volume: 4
  start-page: 215
  year: 1995
  ident: key 20180319053713_ddy030-B15
  article-title: Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene
  publication-title: Hum. Mol. Genet
  doi: 10.1093/hmg/4.2.215
– volume: 28
  start-page: 146
  year: 1982
  ident: key 20180319053713_ddy030-B26
  article-title: Porphobilinogen deaminase: methods and principles of the enzymatic assay
  publication-title: Enzyme
  doi: 10.1159/000459098
– volume: 37
  start-page: 1215
  year: 2016
  ident: key 20180319053713_ddy030-B20
  article-title: Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease
  publication-title: Hum. Mutat
  doi: 10.1002/humu.23067
– volume: 62
  start-page: 1198
  year: 1998
  ident: key 20180319053713_ddy030-B29
  article-title: Multipoint quantitative-trait linkage analysis in general pedigrees
  publication-title: Am. J. Hum. Genet
  doi: 10.1086/301844
– volume: 92
  start-page: 619
  year: 1993
  ident: key 20180319053713_ddy030-B33
  article-title: Detection of a high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyria
  publication-title: Hum. Genet
  doi: 10.1007/BF00420949
– volume: 86
  start-page: 1511
  year: 1990
  ident: key 20180319053713_ddy030-B14
  article-title: Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI114869
– volume: 2
  start-page: 1315
  year: 1993
  ident: key 20180319053713_ddy030-B31
  article-title: Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase
  publication-title: Hum. Mol. Genet
  doi: 10.1093/hmg/2.8.1315
– volume: 36
  start-page: 849
  year: 2013
  ident: key 20180319053713_ddy030-B6
  article-title: The incidence of inherited porphyrias in Europe
  publication-title: J. Inherit. Metab. Dis
  doi: 10.1007/s10545-012-9544-4
– volume: 248
  start-page: 319
  year: 2000
  ident: key 20180319053713_ddy030-B11
  article-title: Renal symptomatology in patients with acute intermittent porphyria. A population-based study
  publication-title: J. Intern. Med
  doi: 10.1046/j.1365-2796.2000.00743.x
– volume: 31
  start-page: 2745
  year: 2015
  ident: key 20180319053713_ddy030-B28
  article-title: PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels
  publication-title: Bioinforma. Oxf. Engl
  doi: 10.1093/bioinformatics/btv195
– volume: 7
  start-page: 535
  year: 2001
  ident: key 20180319053713_ddy030-B17
  article-title: Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients
  publication-title: Mol. Med. Camb. Mass
  doi: 10.1007/BF03401859
– volume: 338
  start-page: 1853
  year: 1998
  ident: key 20180319053713_ddy030-B9
  article-title: Acute hepatic porphyrias and primary liver cancer
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJM199806183382518
– volume: 93
  start-page: 47
  year: 1994
  ident: key 20180319053713_ddy030-B3
  article-title: Detection of eleven mutations causing acute intermittent porphyria using denaturing gradient gel electrophoresis
  publication-title: Hum. Genet
  doi: 10.1007/BF00218912
– volume: 54
  start-page: 69
  year: 2002
  ident: key 20180319053713_ddy030-B5
  article-title: Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients
  publication-title: Hum. Hered
  doi: 10.1159/000067665
– volume: 100
  start-page: 145
  year: 1997
  ident: key 20180319053713_ddy030-B22
  article-title: Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease
  publication-title: Hum. Genet
  doi: 10.1007/s004390050480
– volume: 7
  start-page: 248
  year: 2010
  ident: key 20180319053713_ddy030-B27
  article-title: A method and server for predicting damaging missense mutations
  publication-title: Nat. Methods
  doi: 10.1038/nmeth0410-248
– volume: 65
  start-page: 976
  year: 2012
  ident: key 20180319053713_ddy030-B13
  article-title: Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up
  publication-title: J. Clin. Pathol
  doi: 10.1136/jclinpath-2012-200791
– volume: 420
  start-page: 17
  year: 2009
  ident: key 20180319053713_ddy030-B21
  article-title: Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria
  publication-title: Biochem. J
  doi: 10.1042/BJ20082077
– volume: 55 (Suppl. 2)
  start-page: S119
  year: 2006
  ident: key 20180319053713_ddy030-B18
  article-title: May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population
  publication-title: Physiol. Res. Acad. Sci. Bohemoslov
– volume: 242
  start-page: 213
  year: 1997
  ident: key 20180319053713_ddy030-B19
  article-title: Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France
  publication-title: J. Intern. Med
  doi: 10.1046/j.1365-2796.1997.00189.x
– volume: 66
  start-page: 187
  year: 2000
  ident: key 20180319053713_ddy030-B23
  article-title: Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema
  publication-title: Am. J. Hum. Genet
  doi: 10.1086/302729
SSID ssj0016437
Score 2.531762
Snippet Abstract Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS)...
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene....
SourceID hal
proquest
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1164
SubjectTerms Databases, Nucleic Acid
Endocrinology and metabolism
Female
France
France - epidemiology
Gene-Environment Interaction
Genetics
Hematology
Human genetics
Human health and pathology
Humans
Hydroxymethylbilane Synthase
Hydroxymethylbilane Synthase - genetics
Hépatology and Gastroenterology
Infectious diseases
Life Sciences
Male
Mutation, Missense
Penetrance
Porphyria, Acute Intermittent
Porphyria, Acute Intermittent - enzymology
Porphyria, Acute Intermittent - epidemiology
Porphyria, Acute Intermittent - genetics
Prevalence
Tissues and Organs
Urology and Nephrology
Title From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria
URI https://www.ncbi.nlm.nih.gov/pubmed/29360981
https://www.proquest.com/docview/1990851797
https://hal.science/hal-02351445
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWLpO5vCAUFufaPFYbpWPdNIlV2lsUx05bqU2mkiKNP81f4ByfJE1ZNQ1eoip1I7fnq318Lt_H2AfHDlLcJiw3izLLk4ljSU9EViCFdhJPOpEhez45DYZj79uFf9Hp_G5VLa1K-Tn9tbWv5H-sCvfArtgl-w-WbR4KN-A12BeuYGG43srGA-wNST6pgupZ0I9EpYn5bFLAZ2Yp6dwQKwT2-ZWmP8CEXlsNbtg_UqhZhqLYGP5IUqwdQB4JbPYvsVgAnHQwB1UkN74sxf8Xtb4uijFjR2TjpI90PplTrmO4mhTrlM90UaWkDkgzqMHW1yW2OvxVt2TC5TDvZGWelJDcdx2pEL1WgcsNHZCGVnV8Vgc-quBk4FlIoUy7FC3NXmCD9Un2pl67iVegwmjYWoiFIHL0alMXggRTrm0YRKY1XcC6OlDqyqYkUQs7lwsDHvCKAjsidZlN1u5h_3t8djiIR0enx5vvNvTdw_4ongK6kFsIDrD-Tziu33XgXIOSG4dHx03aC7Oohhyy-vo1n27k7sMU92mCyF9dzWbDmbozxVLejTbNa6cl4zWdP2IPq-MO7xN2H7OOznfZPRJAvdpl90-q0o4nbIlg5gmvwczLgic5X4OZGzDzIuMtMHMEM98AM2_ADAO5ATNvg5k3YH7KxoMv5wdDqxIEsVK3F5aWr-wk8rRwsiCVvUCGgaedzFN-EnhKKiGkp6Vvu06mtWNnqD0pe2Gaaji2q1Bo9xnbyYtcv2BcBVpH4IpnjtJearuRUsJWvur5Sjqh9LvsY_3LxmnFlo-iLfOYqjbcGAwSk0G67H0z9pI4YraOeocYqAdsx0WX7YH9bnzK29q0MWwEmN1Lcl2sfsQC_MoeEu6FXfacbN48p8bLy9vM4RV7sP73vmY75XKl34DnXco9g9Y_AMPdmg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+a+dominant+to+an+oligogenic+model+of+inheritance+with+environmental+modifiers+in+acute+intermittent+porphyria&rft.jtitle=Human+molecular+genetics&rft.au=Lenglet%2C+Hugo&rft.au=Schmitt%2C+Caroline&rft.au=Grange%2C+Thomas&rft.au=Manceau%2C+Hana&rft.date=2018-04-01&rft.pub=Oxford+University+Press+%28OUP%29&rft.issn=0964-6906&rft.eissn=1460-2083&rft.volume=27&rft.issue=7&rft.spage=1164&rft.epage=1173&rft_id=info:doi/10.1093%2Fhmg%2Fddy030&rft_id=info%3Apmid%2F29360981&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_02351445v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0964-6906&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0964-6906&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0964-6906&client=summon